Question · asked by 1 review
Tranexamic acid vs alternative haemostatic agents: Severity of re‐bleeding: proportion of patients requiring blood transfusion within 10 days
- Population
- adults with nasal haemorrhage (epistaxis)
- Intervention
- Tranexamic acid
- Comparison
- alternative haemostatic agents
- Outcome
- Severity of re‐bleeding: proportion of patients requiring blood transfusion within 10 days
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Tranexamic acid vs other haemostatic agent Severity of re‐bleeding: proportion of patients requiring blood transfusion within 10 days · adults with nasal haemorrhage (epistaxis) The review found no eligible studies for this question. Tranexamic acid for patients with nasal haemorrhage (epistaxis) (2018) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Tranexamic acid for patients with nasal haemorrhage (epistaxis) 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Tranexamic acid vs placebo + standard care · adults with nasal haemorrhage (epistaxis) · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.